PURPOSE To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) …

Purpose.—To update key recommendations of the American Society of Clinical
Oncology/College of American Pathologists estrogen receptor (ER) and progesterone …

Context.—Increasing implementation of whole slide imaging together with digital workflow
and advances in computing capacity enable the use of artificial intelligence (AI) in …

The management of patients with breast cancer (BC) relies on the assessment of a defined
set of well-established prognostic and predictive markers. Despite overlap, prognostic …

Although most women with luminal breast cancer do well on endocrine therapy alone, some
will develop fatal recurrence thereby necessitating the need to prospectively determine …

Objectives Pathologic complete response (pCR) rate after neoadjuvant chemotherapy was
compared between 141 estrogen receptor (ER)–negative (43%), 41 low ER+ (13%), 47 …

Biomarker analysis of invasive breast carcinoma is useful for prognosis, as surrogate for
molecular subtypes of breast cancer, and prediction of response to adjuvant and …

Basket trials have emerged as a new class of efficient approaches in oncology to evaluate a
new treatment in several patient subgroups simultaneously. In this article, we extend the key …

Magee Equations™ are multivariable models that can estimate oncotype DX® Recurrence
Score, and Magee Equation 3 has been shown to have chemopredictive value in the …

A subset of patients with ductal carcinoma in situ (DCIS) of the breast develop ipsilateral
invasive breast cancer after breast-conserving surgery with or without adjuvant radiotherapy …